Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;47(2):126-134.
doi: 10.1053/j.semnuclmed.2016.10.002. Epub 2016 Nov 1.

Radioiodine Therapy

Affiliations
Review

Radioiodine Therapy

Markus Luster et al. Semin Nucl Med. 2017 Mar.

Abstract

Radioiodine therapy for benign and malignant thyroid disease rose at the birth of nuclear medicine. Since then, this procedure has been performed countless of times in adult and in pediatric patients alike, and has contributed to a normalization of life expectancy in all but I-131 refractory differentiated thyroid cancer (DTC) cases. As 131I therapy in children is almost exclusively given for DTC, this review of radioiodine therapy in children focuses on patients with malignant thyroid disease. The aim of the present review is to provide an overview of the indications, practical execution, and controversies surrounding 131I therapy for malignant tumors in pediatric patients. In pediatric patients, special considerations apply for 131I therapy for DTC because of differences in biological behavior to adult DTC, differences in dosaging caused by patients' lower bodyweight, and differences in the indication for 131I therapy because of the inherently good prognosis in most patients and potential adverse effects in patients with a long life expectancy. However, if applied correctly, 131I therapy in the hands of expert nuclear medicine physicians is a highly effective oncologic therapy, which has proven to represent an effective and well-tolerated procedure in the management of pediatric patients with DTC.

PubMed Disclaimer

Substances

LinkOut - more resources